# ARRAY BIOPHARMA INC

ARRAY BIOPHARMA INC is a company headquartered in Boulder, CO, United States.

## Company overview

- **Legal name:** ARRAY BIOPHARMA INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Boulder, CO, United States
- **Incorporated in:** DE
- **Fiscal year end:** June 30
- **SEC CIK:** 0001100412

## About

ARRAY BIOPHARMA INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001100412, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-08-14, it reported annual revenue of USD 173,768,000; net income of USD -147,346,000; total assets of USD 460,364,000 for the fiscal period ended 2018-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-06-30)

- **Revenue:** $173.8M (USD 173,768,000)
- **Net income:** -$147.3M (USD -147,346,000)
- **Total assets:** $460.4M (USD 460,364,000)
- **Cash and equivalents:** $114.7M (USD 114,748,000)
- **Operating cash flow:** -$119.8M (USD -119,783,000)

### FY2017 (period ended 2017-06-30)

- **Revenue:** $150.9M (USD 150,852,000)
- **Net income:** -$116.8M (USD -116,818,000)
- **Total assets:** $279.1M (USD 279,145,000)
- **Cash and equivalents:** $125.9M (USD 125,933,000)
- **Operating cash flow:** -$39.4M (USD -39,354,000)

### FY2016 (period ended 2016-06-30)

- **Revenue:** $137.9M (USD 137,879,000)
- **Net income:** -$92.8M (USD -92,840,000)
- **Total assets:** $168.9M (USD 168,900,000)
- **Cash and equivalents:** $56.6M (USD 56,598,000)
- **Operating cash flow:** -$70.1M (USD -70,090,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-06-30)

- **Revenue:** $51.9M (USD 51,909,000)
- **Net income:** $9.4M (USD 9,369,000)
- **Total assets:** $198.2M (USD 198,207,000)
- **Cash and equivalents:** $55.7M (USD 55,691,000)
- **Operating cash flow:** -$5.8M (USD -5,793,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2019-07-30 — period 2019-07-29 — 8-K
- Form 8-K — filed 2019-06-17 — period 2019-06-14 — 8-K
- Form 8-K — filed 2019-05-21 — period 2019-05-21 — 8-K
- Form 10-Q — filed 2019-05-07 — period 2019-03-31 — 10-Q
- Form 8-K — filed 2019-05-07 — period 2019-05-07 — 8-K
- Form 8-K — filed 2019-03-22 — period 2019-03-22 — 8-K
- Form 8-K — filed 2019-03-18 — period 2019-03-18 — 8-K
- Form 8-K — filed 2019-02-20 — period 2019-02-20 — 8-K
- Form 10-Q — filed 2019-02-05 — period 2018-12-31 — 10-Q
- Form 8-K — filed 2019-02-05 — period 2019-02-05 — 8-K
- Form 10-Q — filed 2018-10-30 — period 2018-09-30 — 10-Q
- Form 8-K — filed 2018-10-30 — period 2018-10-30 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/array-biopharma-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology